Product Name | MF | CAS | Details |
---|
DTD1 antibody | Details |
Bisphenol F bis(2,3-dihydroxypropyl) ether | C19H24O6 | 72406-26-9 | Details |
N 161 | C25H50N4O22HCl | 141774-20-1 | Details |
Pkib Blocking Peptide | Details |
CD45.2 antibody (biotin) | Details |
6-Oxo-5,6-dihydro[1,3]dioxolo[4,5-g]quinoline-7-carbaldehyde | C11H7NO4 | 462068-15-1 | Details |
7-Fluoro-1-propyl-1,2,3,4-tetrahydroquinoxaline | C11H15FN2 | 1538546-37-0 | Details |
RAP antibody (39 kDa) | Details |
O-Methylisourea hydrochloride | C2H7ClN2O | 5329-33-9 | Details |
Twist1 antibody | Details |
Virginiamycin S1 | C43H49N7O10 | 23152-29-6 | Details |
(S)-Methyl 5-thioxopyrrolidine-2-carboxylate | C6H9NO2S | 85178-37-6 | Details |
trans,trans-1,4-Diphenyl-1,3-butadiene | C16H14 | 538-81-8 | Details |
5-Acetoxy-7-hydroxyflavone | C17H12O5 | 132351-58-7 | Details |
2-{[(4-Methoxyphenyl)methoxy]methyl}oxirane | C11H14O3 | 80910-01-6 | Details |
LCBiot-GTAG-OH | Details |
(5-Bromo-benzo[b]thiophen-2-yl)-methanol | C9H7BrOS | 13771-72-7 | Details |
4-Hydroxy-N,N-dimethylbenzene-1-sulfonamide | C8H11NO3S | 15020-57-2 | Details |
Diallyl succinate | C10H14O4 | 925-16-6 | Details |
tert-Butyl 2-(2-bromoethyl)morpholine-4-carboxylate | C11H20BrNO3 | 958026-64-7 | Details |
4-(Bromomethyl) benzoic acid | C8H7BrO2 | 6232-88-8 | Details |
2-[(5-Bromopyridin-3-yl)amino]ethan-1-ol | C7H9BrN2O | 1289078-12-1 | Details |
(Lys9,Trp11,Glu12)-Neurotensin (8-13) (Cyclic Analog) | C39H59N11O8 | 160662-16-8 | Details |
H-LFDSLTLLASGR-OH | Details |
HA tag antibody | Details |
2-Methyl-4-(trifluoromethyl)-1,3-oxazole-5-carboxylic acid | C6H4F3NO3 | 499766-90-4 | Details |
4-Bromo-5-chloro-1-benzofuran | C8H4BrClO | 1427405-29-5 | Details |
1,2-Diacetoxybenzene | C10H10O4 | 635-67-6 | Details |
4-[(Benzylamino)methyl]-N,N-dimethylaniline | C16H20N2 | 55096-85-0 | Details |
Thymol | C10H14O | 89-83-8 | Details |
Rhamnocitrin 3-glucoside | C22H22O11 | 41545-37-3 | Details |
3-Chloro-1-{4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}propan-1-one | C10H12ClNOS | 953757-10-3 | Details |
6-Methyl-2-phenylpyrimidin-4-amine | C11H11N3 | 83702-18-5 | Details |
Methyl 5-acetamido-2,5-(tert.butoxycarbonyl)imino-2,5,6-trideoxy-b-D-mannofuranoside | Details |
Cyanidin-3-O-glucuronide | C21H19O12+ | 775284-61-2 | Details |
Tyr-ACTH (4-9) | C51H65N13O11S | Details |
2,6-Diethylbenzene-1-sulfonamide | C10H15NO2S | 1099661-01-4 | Details |
17-DMAG hydrochloride | C32H49ClN4O8 | 467214-21-7 | Details |
H-EVEDPQVAQLELGGGPGAGDLQTLALEVAQQ-OH | Details |
3-chloro-4-iodobenzoic acid | C7H4ClIO2 | 58123-72-1 | Details |
2-Chloro-6-fluoronitrobenzene | C6H3ClFNO2 | 64182-61-2 | Details |
3-Ethyl-3-methylazetidine hydrochloride | C6H14ClN | 1803609-20-2 | Details |
3-{[4-(Diethoxymethyl)-1H-1,2,3-triazol-1-yl]methyl}pyridine | C13H18N4O2 | 1461708-77-9 | Details |
H-VLQWAKKGYYTMKSN-OH | Details |
(2S)-2-Amino-N-ethyl-3-methylbutanamide | C7H16N2O | 169170-45-0 | Details |
BTC protein (His tag) | Details |
NES Topoisomerase II alpha (1017-1028) | Details |
6-Bromo-4,8-dichloroquinoline | C9H4BrCl2N | 1156602-19-5 | Details |
2-[3-(4-Chlorophenyl)-1-phenyl-1H-pyrazol-4-yl]acetic acid | C17H13ClN2O2 | 53808-88-1 | Details |
4-(3-Chlorophenyl)-4-fluoropiperidine hydrochloride | C11H14Cl2FN | 1803581-95-4 | Details |
[1-(Aminomethyl)-4-methylcyclohexyl]methanamine | C9H20N2 | 1507983-56-3 | Details |
Tryptamine-α,α-d2 hydrochloride | C10H13ClN2 | 362049-49-8 | Details |
C-Demethyl formoterol hemifumarate | C18H22N2O4 | 1224588-66-2 | Details |
TNFSF9 antibody (FITC) | Details |
tert-Butyl N-[(4-carbamoylfuran-2-yl)methyl]carbamate | C11H16N2O4 | 1803587-45-2 | Details |
Maleopimaric acid | C24H32O5 | 510-39-4 | Details |
(R)-(-)-3-Hydroxytetrahydrofuran | C4H8O2 | 86087-24-3 | Details |
Maltotetraose 2-aminobenzamide | C31H50N2O22 | Details |
Toxoplasma gondii IgG Positive, EBV VCA & EBNA IgG Negative EDTA Plasma | Details |
5-Chlorofuran-2-carbonitrile | C5H2ClNO | 57240-59-2 | Details |
3-Chloro-4-hydroxybenzene-1-carbothioamide | C7H6ClNOS | 35613-43-5 | Details |
4-Chloro-2,3,5,6-tetrafluoroaniline | C6H2ClF4N | 4218-94-4 | Details |
N-(5-Bromo-1,3-thiazol-2-yl)cyclopropanecarboxamide | C7H7BrN2OS | 20415-77-4 | Details |
4-(2-Methyloxetan-2-yl)benzoate lithium | 2138042-45-0 | Details |
1-(1,2,3-Thiadiazol-4-yl)ethan-1-one | C4H4N2OS | 27643-14-7 | Details |
3-(Methylamino)benzamide hydrochloride | C8H11ClN2O | 2361676-45-9 | Details |
RMC-0331 | C22H25ClF3N5O3 | 2488788-52-7 | Details |
3-Cyclopropanecarbonyl-4H-1,2,4-triazole | C6H7N3O | 1494921-98-0 | Details |
5-Bromo-N-(1-methyl-1H-pyrazol-4-yl)pyrimidin-2-amine | C8H8BrN5 | 1275374-10-1 | Details |
1-[4-(Hydroxymethyl)phenyl]pyrrolidin-2-one | C11H13NO2 | 1204311-22-7 | Details |
3-(difluoromethyl)-1,2-oxazole-5-carboxylic acid | C5H3F2NO3 | 1935503-24-4 | Details |
(2S)-3-Methyl-2-(phenylamino)butanoic acid | C11H15NO2 | 21671-21-6 | Details |
5-(3-Fluorophenyl)-2-thiophenecarbaldehyde | C11H7FOS | 886508-77-6 | Details |
H-Met-Gly-Met-Met-OH | C17H32N4O5S3 | 14517-45-4 | Details |
LMF1 antibody | Details |
2-Chloro-N-{[4-(pyrrolidin-1-ylmethyl)phenyl]methyl}acetamide hydrochloride | C14H20Cl2N2O | 1311317-48-2 | Details |
5-(Piperidin-4-yl)-1,3,4-oxadiazole-2-thiol | C7H11N3OS | 1046203-51-3 | Details |
H-IFYNQQNHYDGSTGK-OH | Details |
ERLIN2 antibody | Details |
3-[(5,6-Dimethyl-1H-1,3-benzodiazol-1-yl)methyl]furan-2-carboxylic acid | C15H14N2O3 | 1094299-09-8 | Details |
Methyl 4,6-O-(4-methoxybenzylidene)-2,3-di-O-pivaloyl-a-D-glucopyranoside | C25H36O9 | Details |
Ethofumesate-2-hydroxy | C11H14O5S | 26322-82-7 | Details |
IL12B antibody (FITC) | Details |
7-Fluoronaphthalen-1-amine | C10H8FN | 13916-95-5 | Details |
2-(4-Methoxyphenyl)thiazole-4-carboxylic acid | C11H9NO3S | 57677-80-2 | Details |
1,8-Cineol-d3 | C10H18O | 1216822-66-0 | Details |
2-(4-Chlorophenyl)-2H-1,2,3-triazole-4-carboxylic acid | C9H6ClN3O2 | 89522-59-8 | Details |
1-[5-(2-Chlorophenyl)thiophen-2-yl]ethan-1-one | C12H9ClOS | 893735-05-2 | Details |
3-(2,5-Dichlorobenzoyl)oxolane | C11H10Cl2O2 | 1248215-19-1 | Details |
Integrin Beta 8 Blocking Peptide | Details |
3-Methoxy-2,2-dimethylcyclobutan-1-amine | C7H15NO | 1384430-73-2 | Details |
3-(Quinolin-7-yl)propanoic acid | C12H11NO2 | 1368259-20-4 | Details |
6-Methoxychroman-3-one | C10H10O3 | 76322-25-3 | Details |
Lithium(1+) ion indolizine-3-carboxylate | C9H8LiNO2 | 2378503-33-2 | Details |
Methyl 3-chloro-5H,6H,7H-cyclopenta[C]pyridazine-4-carboxylate | C9H9ClN2O2 | 2091710-34-6 | Details |
H-GAHWQFNAL-OH | Details |
Hamaudol | C15H16O5 | 735-46-6 | Details |
RPC8 antibody | Details |
GPR75 Blocking Peptide | Details |
(3-Chloropropyl)(pyridin-4-ylmethyl)amine dihydrochloride | C9H15Cl3N2 | 1375474-23-9 | Details |
Product Total: Product Page: | ||||
511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 |